Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma

NCT06474481 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

FL

Interventions

DRUG: Zanubrutinib
DRUG: Obinutuzumab
DRUG: Prednisone
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Doxorubicin

Sponsor

Tianjin Medical University Cancer Institute and Hospital